A respiratory syncytial virus persistent-infected cell line system reveals the involvement of SOCS1 in the innate antiviral response

Virologica Sinica

Volumn 30, Issue 3, 2015, Pages 190-199

  Zheng, Junwen ^a   Yang, Pu ^a   Tang, Yan ^b   Zhao, Dongchi ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

interferon; respiratory syncytial virus (RSV); RSV persistent cell line; suppressor of cytokine signaling 1 (SOCS1); toll like receptor 3 (TLR3)

Indexed keywords

BETA INTERFERON; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1; MESSENGER RNA; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR 3; VIRUS ANTIGEN; CYTOKINE; SOCS1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; GENE EXPRESSION; GENE SILENCING; HEP 2 CELL LINE; HUMAN; HUMAN CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INNATE IMMUNITY; NONHUMAN; PROTEIN PHOSPHORYLATION; UPREGULATION; VIRUS IMMUNITY; VIRUS REPLICATION; CELL LINE; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; SECRETION (PROCESS);

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

CELL LINE; CYTOKINES; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; RESPIRATORY SYNCYTIAL VIRUSES; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84933517235     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-015-3597-0     Document Type: Article

References (31)

1. Baetz A, Frey M, Heeg K, Dalpke AH. 2004. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells. J Biol Chem, 279: 54708–54715.
2. Bangham CRM, McMichael AJ. 1986. Specific human cytotoxic T cells recognize B cell lines persistently infected with respiratory syncytial virus. Proc Natl Acad Sci USA, 83: 9183–9187.
3. Bode JG, Ludwig S, Ehrhardt C, Albrecht U, Erhardt A, Schaper F, Heinrich PC, Häussinger D. 2003. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. Faseb J, 17: 488–490.
4. Borg I, Rohde G, Löseke S, Bittscheidt J, Schultze-Werninghaus G, Stephan V, Bufe A. 2003. Evaluation of quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases. Eur Respir J, 21: 944–951.
5. Dalpke A, Heeg K, Bartz H, Baetz A. 2008. Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins. Immunobiology, 213: 225–235.
6. Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE. 2006. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 173:639–643.
7. Groskreutz DJ, Monick MM, Powers LS, Yarovinsky TO, Look DC, Hunninghake GW. 2006. Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. J Immunol, 176: 1733–1740.
8. Hashimoto K, Ishibashi K, Ishioka K, Zhao D, Sato M, Ohara S, Abe Y, Kawasaki Y, Sato Y, Yokota S, Fujii N, Peebles RS Jr, Hosoya M, Suzutani T. 2009. RSV replication is attenuated by counteracting expression of the suppressor of cytokine signaling (SOCS) molecules. Virology, 391:162–170.
9. Herranz C, Melero JA, Martínez I. 2011. Reduced innate immune response, apoptosis, and virus release in cells cured of respiratory syncytial virus persistent infection. Virology, 410: 56–63.
10. Hobson L, Everard ML. 2008. Persistent of respiratory syncytial virus in human dendritic cells and influence of nitric oxide. Clin Exp Immun, 151: 359–366.
11. Jeanette I, Webster M, Jacqueline C. 2013. Poly I:C and respiratory syncytial virus (RSV) inhibit glucocorticoid receptor (GR)-mediated transactivation in lung epithelial, but not monocytic, cell lines. Virus Res,176: 303–306.
12. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, Si-Tahar M. 2007. Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol, 178: 3368–3372.
13. Liu P, Jamaluddin M, Li K, Garofalo RP, Casola A, Brasier AR. 2007. Retinoic acid inducible gene-I mediates early anti-viral response and toll like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol, 81: 1401–1411.
14. Martínez I, Lombardía L, Herranz C, García-Barreno B, Domínguez O, Melero JA. 2009. Cultures of HEp-2 cells persistently infected by human respiratory syncytial virus differ in chemokine expression and resistance to apoptosis as compared to lytic infections of the same cell type. Virology, 388: 31–41.
15. Matsuse H, Behera AK, Kumar M, Rabb H, Lockey RF, Mohapatra SS. 2000. Recurrent respiratory syncytial virus infections in allergen-sensitized mice lead to persistent airway inflammation and hyperresponsiveness. J Immunol, 164: 6583–6592.
16. Oshansky CM, Krunkosky TM, Barber J, Jones LP, Tripp RA. 2009. Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway. Viral Immunol, 22: 147–161.
17. Pothlichet J, Chignard M, Si-Tahar M. 2008. Cutting Edge: Innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. J Immunol, 80: 2034–2038.
18. Prêle CM, Woodward EA, Bisley J, Keith-Magee A, Nicholson SE, Hart PH. 2008. SOCS1 regulates the IFN but not NFκB pathway in TLR-stimulated human monocytes and macrophages. J Immunol, 181: 8018–8026.
19. Psarras S, Papadopoulos NG, Johnston SL. 2004. Pathogenesis of respiratory syncytial virus bronchiolitis-related wheezing. Paediatr Respir Rev, (Suppl A): 179–184.
20. Riedel F, Oberdieck B, Streckert HJ, Philippou S, Krusat T, Marek W. 1997. Persistence of airway hyperresponsiveness and viral antigen following respiratory syncytial virus bronchiolitis in young guinea-pigs. Eur Respir J, 10: 639–645.
21. Schwarze J, O’Donnell DR, Rohwedder A, Openshaw PJ. 2004. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med, 169: 801–805.
22. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA. 2001. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 164: 1618–1623.
23. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. 2000. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit. Care Med, 161: 1501–1507.
24. Sikkel MB, Quint JK, Mallia P, Wedzicha JA, Johnston SL. 2008. Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr Infect Dis J, 27(Suppl): 63–70.
25. Stowell NC, Seideman J, Raymond HA, Smalley KA, Lamb RJ, Egenolf DD, Bugelski PJ, Murray LA, Marsters PA, Bunting RA, Flavell RA, Alexopoulou L, San Mateo LR, Griswold DE, Sarisky RT, Mbow ML, Das AM. 2009. Long-term activation of TLR3 by Poly (I: C) induces inflammation and impairs lung function in mice. Respir Res, 10: 43.
26. Tripp RA. 2004. The brume surrounding respiratory syncytial virus persistence. Am. J Respir Crit Care Med, 169: 778–779.
27. Valdovinos MR, Gomez B. 2003. Establishment of respiratory syncytial virus persistence in cell lines: association with defective interfering particles. Intervirology, 46:190–198.
28. Vlotides G, Sörensen AS, Kopp F, Zitzmann K, Cengic N, Brand S, Zachoval R, Auernhammer CJ. 2004. SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA. Biochem Biophys Res Commun, 320: 1007–1014.
29. Xu X, Zheng J, Zheng K, Hou Y, Zhao F, Zhao D. 2014. Respiratory syncytial virus NS1 protein degrades STAT2 by inducing SOCS1 expression. Intervirology, 57: 65–73.
30. Yasukawa H, Yajima T, Duplain H, Iwatate M, Kido M, Hoshijima M, Weitzman MD, Nakamura T, Woodard S, Xiong D, Yoshimura A, Chien KR, Knowlton KU. 2003. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J Clin Invest, 111: 469–478.
31. Zhao DC, Tang Y, Li L, You SY, Zhang CY. 2007. Respiratory syncytial virus inhibits interferon-a-inducible signaling in macrophage- like U937 cells. J Infect, 54: 393–398.